Literature DB >> 24081906

Role of mitofusin 2 (Mfn2) in controlling cellular proliferation.

Kuang-Hueih Chen1, Asish Dasgupta, Jinhui Ding, Fred E Indig, Paritosh Ghosh, Dan L Longo.   

Abstract

It has been reported that Mitofusin2 (Mfn2) inhibits cell proliferation when overexpressed. We wanted to study the role of endogenous Mfn2 in cell proliferation, along with the structural features of Mfn2 that influence its mitochondrial localization and control of cell proliferation. Mfn2-knockdown clones of a B-cell lymphoma cell line BJAB exhibited an increased rate of cell proliferation. A 2-fold increase in cell proliferation was also observed in Mfn2-knockout mouse embryonic fibroblast (MEF) cells as compared with the control wild-type cells, and the proliferative advantage of the knockout MEF cells was blocked on reintroduction of the Mfn2 gene. Mfn2 exerts its antiproliferative effect by acting as an effector molecule of Ras, resulting in the inhibition of the Ras-Raf-ERK signaling pathway. Furthermore, both the N-terminal (aa 1-264) and the C-terminal (aa 265-757) fragments of Mfn2 blocked cell proliferation through distinct mechanisms: the N-terminal-mediated inhibition was due to its interaction with Raf-1, whereas the C-terminal fragment of Mfn2 inhibited cell proliferation by interacting with Ras. The inhibition of proliferation by the N-terminal fragment was independent of its mitochondrial localization. Collectively, our data provide new insights regarding the role of Mfn2 in controlling cellular proliferation.

Entities:  

Keywords:  ERK; HSG; Raf; Ras

Mesh:

Substances:

Year:  2013        PMID: 24081906      PMCID: PMC3868832          DOI: 10.1096/fj.13-230037

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  26 in total

1.  RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor.

Authors:  Michele D Vos; Chad A Ellis; Candice Elam; Aylin S Ulku; Barbara J Taylor; Geoffrey J Clark
Journal:  J Biol Chem       Date:  2003-05-05       Impact factor: 5.157

2.  Unravelling Ras signals in cardiovascular disease.

Authors:  Kenneth R Chien; Masahiko Hoshijima
Journal:  Nat Cell Biol       Date:  2004-09       Impact factor: 28.824

3.  Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A.

Authors:  Stephan Züchner; Irina V Mersiyanova; Maria Muglia; Nisrine Bissar-Tadmouri; Julie Rochelle; Elena L Dadali; Mario Zappia; Eva Nelis; Alessandra Patitucci; Jan Senderek; Yesim Parman; Oleg Evgrafov; Peter De Jonghe; Yuji Takahashi; Shoij Tsuji; Margaret A Pericak-Vance; Aldo Quattrone; Esra Battaloglu; Alexander V Polyakov; Vincent Timmerman; J Michael Schröder; Jeffery M Vance; Esra Battologlu
Journal:  Nat Genet       Date:  2004-04-04       Impact factor: 38.330

4.  Ras-GAP controls Rho-mediated cytoskeletal reorganization through its SH3 domain.

Authors:  V Leblanc; B Tocque; I Delumeau
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

Review 5.  Ras effectors and their role in mitogenesis and oncogenesis.

Authors:  T Joneson; D Bar-Sagi
Journal:  J Mol Med (Berl)       Date:  1997-08       Impact factor: 4.599

6.  Mitofusin2 mutations disrupt axonal mitochondrial positioning and promote axon degeneration.

Authors:  Albert L Misko; Yo Sasaki; Elizabeth Tuck; Jeffrey Milbrandt; Robert H Baloh
Journal:  J Neurosci       Date:  2012-03-21       Impact factor: 6.167

7.  Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.

Authors:  L Naldini; U Blömer; F H Gage; D Trono; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

8.  RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family.

Authors:  Kristin Eckfeld; Luke Hesson; Michele D Vos; Ivan Bieche; Farida Latif; Geoffrey J Clark
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

9.  Dysregulation of HSG triggers vascular proliferative disorders.

Authors:  Kuang-Hueih Chen; Xiaomei Guo; Dalong Ma; Yanhong Guo; Qian Li; Dongmei Yang; Pengfei Li; Xiaoyan Qiu; Shaojun Wen; Rui-Ping Xiao; Jian Tang
Journal:  Nat Cell Biol       Date:  2004-08-22       Impact factor: 28.824

10.  Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo.

Authors:  Manuel Rojo; Frédéric Legros; Danielle Chateau; Anne Lombès
Journal:  J Cell Sci       Date:  2002-04-15       Impact factor: 5.285

View more
  49 in total

1.  Effect of photobiomodulation on mitochondrial dynamics in peripheral nervous system in streptozotocin-induced type 1 diabetes in rats.

Authors:  Igor Rafael Correia Rocha; Edward Perez-Reyes; Marucia Chacur
Journal:  Photochem Photobiol Sci       Date:  2021-02-18       Impact factor: 3.982

Review 2.  Metabolic implications of organelle-mitochondria communication.

Authors:  Isabel Gordaliza-Alaguero; Carlos Cantó; Antonio Zorzano
Journal:  EMBO Rep       Date:  2019-08-14       Impact factor: 8.807

Review 3.  Mitochondrial dynamics and their potential as a therapeutic target.

Authors:  B N Whitley; E A Engelhart; S Hoppins
Journal:  Mitochondrion       Date:  2019-06-19       Impact factor: 4.160

Review 4.  Mitochondrial Morphofunction in Mammalian Cells.

Authors:  Elianne P Bulthuis; Merel J W Adjobo-Hermans; Peter H G M Willems; Werner J H Koopman
Journal:  Antioxid Redox Signal       Date:  2018-11-29       Impact factor: 8.401

5.  MiR-106b-mediated Mfn2 suppression is critical for PKM2 induced mitochondrial fusion.

Authors:  Haili Wu; Zhuoyu Li; Yingying Wang; Peng Yang; Zongrui Li; Hanqing Li; Changxin Wu
Journal:  Am J Cancer Res       Date:  2016-10-01       Impact factor: 6.166

Review 6.  Translational Advances in the Field of Pulmonary Hypertension. From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs.

Authors:  Soni Savai Pullamsetti; Rajkumar Savai; Werner Seeger; Elena A Goncharova
Journal:  Am J Respir Crit Care Med       Date:  2017-02-15       Impact factor: 21.405

7.  Mitofusion 2 Overexpression Decreased Proliferation of Human Embryonic Lung Fibroblasts in Acute Respiratory Distress Syndrome through Inhibiting RAS-RAF-1-ERK1/2 Pathway.

Authors:  Juan Li; Mei-Xia Xu; Zhong Dai; Tao Xu
Journal:  Curr Med Sci       Date:  2021-01-11

8.  Transcriptional profiling revealed the anti-proliferative effect of MFN2 deficiency and identified risk factors in lung adenocarcinoma.

Authors:  Yuqing Lou; Yanwei Zhang; Rong Li; Ping Gu; Liwen Xiong; Hua Zhong; Wei Zhang; Baohui Han
Journal:  Tumour Biol       Date:  2016-01-06

9.  Metabolic Stress-Induced Phosphorylation of KAP1 Ser473 Blocks Mitochondrial Fusion in Breast Cancer Cells.

Authors:  Chun-Ting Cheng; Ching-Ying Kuo; Ching Ouyang; Chien-Feng Li; Yiyin Chung; David C Chan; Hsing-Jien Kung; David K Ann
Journal:  Cancer Res       Date:  2016-06-30       Impact factor: 12.701

10.  Activation of Mitofusin2 by Smad2-RIN1 Complex during Mitochondrial Fusion.

Authors:  Sanjay Kumar; Christopher C Pan; Nirav Shah; Sarah E Wheeler; Kari R Hoyt; Nadine Hempel; Karthikeyan Mythreye; Nam Y Lee
Journal:  Mol Cell       Date:  2016-05-12       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.